Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$39,627,153
+$8,947,593 QoQ
Shares Held
109,431
+25.5% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#244
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $371,290,075 across 10 Drug Manufacturers - General names. AMGN ranks #4 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
90,318 | $108,330,127 | |
| 2 | JNJ |
Johnson & Johnson
|
265,811 | $67,508,019 | |
| 3 | ABBV |
AbbVie Inc.
|
206,756 | $52,028,079 | |
| 4 | AMGN |
Amgen Inc
This page
|
109,431 | $39,627,153 | |
| 5 | MRK |
Merck & Co., Inc.
|
273,534 | $35,149,119 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
264,468 | $33,412,887 | |
| 7 | PFE |
Pfizer Inc
|
635,140 | $15,294,171 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
228,360 | $13,158,103 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,627,153 | 109,431 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $30,679,560 | 87,195 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $37,646,541 | 115,018 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $37,126,514 | 131,561 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $36,434,392 | 130,491 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $38,791,090 | 124,510 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $41,403,185 | 158,852 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $45,180,608 | 140,221 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $50,222,275 | 160,737 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $38,390,308 | 135,025 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $36,615,694 | 127,129 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $32,908,318 | 122,445 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $26,807,582 | 120,744 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $24,261,063 | 100,356 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $24,013,963 | 91,433 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $19,316,780 | 85,700 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,702,169 | 56,318 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $16,580,388 | 68,565 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $14,051,851 | 62,461 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $11,031,431 | 51,876 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $9,465,543 | 38,833 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $10,367,663 | 41,669 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $7,518,154 | 32,699 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $8,327,552 | 32,765 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $10,353,074 | 43,895 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $3,901,741 | 19,246 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||